Suspended NA INTERVENTIONAL 2-arm NCT03709992

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms: A Randomized Controlled Trial

Sponsor: Amiri Hospital

Conditions Quality of Life Ureter Obstruction Ureter Stone

Interventions Tamsulosin Trospium Chloride

Updated 10 times since 2018 Last updated: Oct 10, 2023 Started: Dec 18, 2020 Primary completion: Aug 1, 2024 Completion: Nov 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Because of COVID-19 Crisis

This NA trial investigates Quality of Life and Ureter Obstruction and is currently suspended. Amiri Hospital leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Suspended NA
Sep 2024 — Sep 2025 [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
Nov 2023 — Jul 2024 [monthly]

Suspended NA

Status: Unknown Status → Suspended
Feb 2023 — Nov 2023 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 5 earlier versions

Jan 2021 — Feb 2023 [monthly]

Recruiting NA

Status: Suspended → Recruiting
May 2020 — Jan 2021 [monthly]

Suspended NA

Status: Recruiting → Suspended
Mar 2020 — May 2020 [monthly]

Recruiting NA
Jan 2019 — Mar 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Nov 2018 — Jan 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amiri Hospital
Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt